The host-directed therapeutic imatinib mesylate accelerates immune responses to Mycobacterium marinum infection and limits pathology associated with granulomas is a research paper published in PLoS Pathogens (2023). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01-DK074731
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R56-DK074731
National Institute on Aging
Grant: R21-AG054903
National Institute of Allergy and Infectious Diseases
Grant: UH2/3 AI-122320
NIDDK NIH HHS
Grant: R56 DK074731
NIAID NIH HHS
Grant: UH2 AI122320
NIAID NIH HHS
Grant: P30 AI168386
NIAID NIH HHS
Grant: UH3 AI122320
NIDDK NIH HHS
Grant: R01 DK074731
NIA NIH HHS
Grant: R21 AG054903
National Institutes of Health
Grant: 5R01DK074731-02
A C.elegans model for EPEC and EHEC pathogenesis
National Institutes of Health
Grant: 1R21AG054903-01A1
Intestinal microbiota effects on damage tolerance in aging
National Institutes of Health
Grant: 5UH3AI122320-05
Development of Gleevec for TB and TB/HIV
FWCI
1.85
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals